ebook Munafa Stock Market Course + Intraday & FNO calls  

       

524816 announcements Natco Pharm announcements and dividends declared BSE

Natco Pharm Complete list of announcements declared & dividend announcements by Natco Pharm 524816

Natco Pharm 524816 listed on BSE and deals in

Announcements and dividends declared by Natco Pharm 524816

Accumulate NATCO Pharma; target of Rs 1116: Geojit Financial Services
Geojit Financial Services recommended accumulate rating on NATCO Pharma with a target price of Rs 1116 in its research report dated March 27, 2024.
Announcement as on 27 March 2024

Delhi HC bars Natco Pharma from selling cancer drug Olaparib
The Delhi High Court has prohibited Natco Pharma from producing and selling the cancer drug Olaparib, marketed as 'BRACANAT' or under any other name, until further notice. The court's decision came in response to a lawsuit by Kudos Pharmaceuticals, which c
Announcement as on 04 March 2024

Natco Pharma Q3 net profit rises over 3-fold to Rs 212.7 crore
The company had posted a consolidated net profit of Rs 62.3 crore in the same period last fiscal, Natco Pharma said in a regulatory filing.
Announcement as on 14 February 2024

Natco Pharma Q3 net profit rises over 3-fold to Rs 212.7 crore
The company had posted a consolidated net profit of Rs 62.3 crore in the same period last fiscal, Natco Pharma said in a regulatory filing.
Announcement as on 14 February 2024

Natco Pharma Q3 results: Net profit rises over 3-fold to Rs 212.7 crore
Natco Pharma Ltd on Wednesday reported over three-fold rise in consolidated net profit at Rs 212.7 crore in the third quarter ended December 31, 2023 on the back of robust revenue growth. The company had posted a consolidated net profit of Rs 62.3 crore in
Announcement as on 14 February 2024

Announcements by Natco Pharm first page | Next page | Prev page |

524816 Natco Pharm current price & indicator signals

Moving Averages for Natco Pharm

  • 5Day Average: 908.21
  • 12Day Average: 885.62
  • 20Day Average: 887.33
  • 50Day Average: 1031.87
  • 100Day Average: 992.42
  • 150Day Average: 957.06
  • 200Day Average: 925.53

524816 Indicators & signals

Indicator MACD (12,26,9)

904.01, 938.83, -48.89
Indicator MACD is in negative zone

Indicator ADX (14)

2.02, 21.86, 22.76
Indicator ADX is indicating that momentum is weak.
Momentum is towards selling.

Indicator RSI (14)

Current RSI is: 39
Indicator RSI is indicating selling pressure and stock might fall.

Recent prices of 524816 Natco Pharm are as follows: Daily volume is divided by 10 day averaged volume

Date Close Range Change % Volume
30 Tue Jun 2026 931.85 915.25 to 934.75 1.41% 0.37 times
29 Mon Jun 2026 918.85 890.50 to 924.00 1.7% 0.67 times
25 Thu Jun 2026 903.45 894.95 to 918.10 1.06% 1.54 times
24 Wed Jun 2026 893.95 890.00 to 913.35 0.11% 1 times
23 Tue Jun 2026 892.95 885.25 to 913.00 0.97% 1.93 times
22 Mon Jun 2026 884.35 881.80 to 892.75 -0.5% 0.21 times
19 Fri Jun 2026 888.75 877.00 to 909.00 0.62% 0.59 times
18 Thu Jun 2026 883.25 862.80 to 895.80 1.86% 1.61 times
17 Wed Jun 2026 867.10 844.05 to 869.00 1.83% 0.97 times
16 Tue Jun 2026 851.55 841.50 to 858.25 0.47% 0.33 times
15 Mon Jun 2026 847.55 839.80 to 888.95 -1.89% 1.15 times
12 Fri Jun 2026 863.85 849.75 to 866.00 2.53% 0.78 times

Videos related to: 524816 announcements Natco Pharm announcements and dividends declared BSE

Hindi Video Most Important Stock Market Video. No Success Without This Formula

Hindi Video What Is Needed To Succeed In Stock Markets

524816 announcements Natco Pharm announcements and dividends declared BSE

 

Back to top